 |
 |

Alprazolam vs Amitriptyline in Depressions With Reduced REM Latencies
A. John Rush, MD;
Milton K. Erman, MD;
Michael A. Schlesser, MD;
Howard P. Roffwarg, MD;
Nishendu Vasavada, MD;
Manoochehr Khatami, MD;
Carol Fairchild, MSN;
Donna E. Giles, PhD
Arch Gen Psychiatry. 1985;42(12):1154-1159.
Abstract
 |  |
This study was designed to compare the antidepressant effects of alprazolam, a triazolobenzodiazepine, with amitriptyline hydrochloride in a group of patients with nonpsychotic, major depressions diagnosed by Research Diagnostic Criteria. A mean rapid eye movement latency of less than 65 minutes was required to enter this study. Dexamethasone suppression tests were conducted before treatment. By strictly applied Research Diagnostic Criteria, 83.6% of the subjects were endogenous, and 34.7% were inpatients. A significantly greater percentage of alprazolam-treated patients responded within the first seven days of treatment. By the end of this sixweek trial, alprazolam was associated with significant reductions in Hamilton, Beck, Covi, Raskin, and Carroll Rating scores (pretreatment to posttreatment). However, by the end of treatment the effects of amitriptyline exceeded those of alprazolam on both the Hamilton and Beck scales. These data indicate that alprazolam is not as effective as amitriptyline in major depressions with a shortened rapid eye movement latency.
Author Affiliations
From the Affective Disorders Unit, Department of Psychiatry, University of Texas Health Science Center, Dallas.
Footnotes
Accepted for publication Oct 24, 1984.
Read in part before the Psychiatric Research Society, Galveston, Tex, Nov 19, 1982.
Reprint requests to Department of Psychiatry, University of Texas Health Science Center, 5323 Harry Hines Blvd, Dallas, TX 75235 (Dr Rush).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Depression in Panic Disorder and Response to Alprazolam Therapy-Reply
Lesser and Rubin
Arch Gen Psychiatry 1989;46:1053-1054.
ABSTRACT
Predictors of Drug Response in Depression
Joyce and Paykel
Arch Gen Psychiatry 1989;46:89-99.
ABSTRACT
Pharmacotherapy of Borderline Personality Disorder: Alprazolam, Carbamazepine, Trifluoperazine, and Tranylcypromine
Cowdry and Gardner
Arch Gen Psychiatry 1988;45:111-119.
ABSTRACT
Alprazolam, Diazepam, Imipramine, and Placebo in Outpatients With Major Depression
Rickels et al.
Arch Gen Psychiatry 1987;44:862-866.
ABSTRACT
Polysomnographic Findings in Recently Drug-Free and Clinically Remitted Depressed Patients
Rush et al.
Arch Gen Psychiatry 1986;43:878-884.
ABSTRACT
|